Food noise is the constant mental preoccupation with food. Research shows it is driven by hormonal and neurological patterns, not willpower. It is measurable and treatable.

What is the Quiet Rewire Release method?

A 6-month physician-supervised weight loss program with three phases: Quiet (calm food noise), Rewire (build sustainable habits), and Release (life-proof your results).

Does Dr. Ty prescribe medications as part of the program?

Medication decisions are made on an individual basis during the physician assessment. Dr. Tyebjee evaluates each patient's history, symptoms, and clinical picture before making any recommendations.

Is this program available in my state?

Dr. Tyebjee is licensed in 15+ US states. The program is fully virtual. Book a physician assessment to confirm availability.

Do I need to take GLP-1 medication to join the program?

No. QRR works with or without GLP-1 medication. The behavioral rewiring, food noise reduction, hormonal assessment, and weekly physician guidance all work independently of medication. Many women discover their resistance has nothing to do with medication.

How much does a clinic visit cost?

Each visit is $150. Continuing care is normally one visit a month. There are no commitments, and you pay after each visit. Medication, pharmacy, and labs are separate.

What is food noise and can it be treated?

Food noise is the constant mental preoccupation with food — thinking about what to eat, what you already ate, and what you should not eat next. It is a measurable biological signal driven by hormonal and neurological patterns, not willpower. It can be quieted through the QRR method.

Conditions · Early menopause & POI · 100% virtual

Early menopause and POI: when your body is ahead of the calendar

The short answer

Menopause before 45 is early; ovarian insufficiency before 40 is premature — and both carry different stakes than menopause at 52. Unless something specific rules it out, guidelines generally recommend hormone therapy through the typical age of natural menopause, to protect bone and cardiovascular health — not only to relieve symptoms. This is routinely missed in younger women.

Medically reviewed by Dr. Zuleikha Tyebjee, MD, Board-Certified Family Medicine · Reviewed August 11, 2026

Why early isn't just 'the same thing sooner'

When menopause arrives at the typical age, hormone therapy is a quality-of-life decision. When it arrives a decade early, it's also a long-term health decision: those are years your bones, heart, and brain would ordinarily have had estrogen. That's why the guideline stance is different here — treatment until around the typical age of menopause is generally recommended rather than merely offered, absent a contraindication.

POI is also the most-missed diagnosis in this field. Women in their 30s with irregular cycles, hot flashes, or infertility are told they're stressed, that they're too young for menopause, or that their labs are "borderline." The average woman with POI sees multiple clinicians before someone names it. If your cycles have changed meaningfully before 40, that deserves a real workup — not reassurance.

And POI isn't always permanent or absolute: ovarian function can fluctuate, and pregnancy — while less likely — is not impossible. That changes contraception conversations, lab interpretation, and how we talk about the future. It's one more reason this diagnosis needs ongoing physician attention rather than a one-time label.

POI and early menopause vs. typical-age menopause

Typical-age menopause (~51)

Hormone therapy is primarily a symptom-relief decision

Early menopause / POI

Hormone therapy is generally recommended until ~51 for long-term protection, absent contraindications

Typical-age menopause (~51)

Bone loss begins from a full adult baseline

Early menopause / POI

More years without estrogen — bone density needs earlier, closer attention

Typical-age menopause (~51)

Cardiovascular risk rises gradually after the transition

Early menopause / POI

Earlier estrogen loss is associated with higher long-term cardiovascular risk

Typical-age menopause (~51)

Diagnosis is rarely controversial

Early menopause / POI

Routinely missed — often dismissed as stress or 'too young'

Typical-age menopause (~51)

Fertility conversation is usually closed

Early menopause / POI

Ovarian function can fluctuate in POI; contraception and fertility both stay on the table

Typical-age menopause (~51)

Standard-dose therapy

Early menopause / POI

Often higher estrogen doses than typical-age regimens, titrated to the situation

Typical-age menopause (~51)	Early menopause / POI
Hormone therapy is primarily a symptom-relief decision	Hormone therapy is generally recommended until ~51 for long-term protection, absent contraindications
Bone loss begins from a full adult baseline	More years without estrogen — bone density needs earlier, closer attention
Cardiovascular risk rises gradually after the transition	Earlier estrogen loss is associated with higher long-term cardiovascular risk
Diagnosis is rarely controversial	Routinely missed — often dismissed as stress or 'too young'
Fertility conversation is usually closed	Ovarian function can fluctuate in POI; contraception and fertility both stay on the table
Standard-dose therapy	Often higher estrogen doses than typical-age regimens, titrated to the situation

What I weigh before prescribing anything

Confirming the diagnosis properly

POI has specific criteria — cycle history plus repeated labs. A single borderline FSH is not a diagnosis, and neither is a hunch.

What caused it, when findable

Autoimmune disease, genetics, surgery, chemotherapy or radiation each change surveillance and sometimes treatment.

Bone and cardiovascular protection

The point of treatment here is partly what you can't feel: preserving bone density and long-term cardiovascular health through the missing years.

Dose and route for your age

Younger bodies often need more estrogen than standard menopausal doses; route and formulation are chosen around your specific risks.

Fertility and contraception honestly

POI is not absolute sterility. If pregnancy would be welcome — or wouldn't — the plan has to account for it either way.

Questions worth asking any doctor — including me

Bring these to your next appointment, wherever it is. A doctor who welcomes them is a good sign.

Do my labs actually meet criteria for POI, or is this one borderline result?
Should I be tested for causes — autoimmune, genetic, or related to past treatment?
What's your plan for my bone density, starting when?
What estrogen dose am I on compared with what someone my age typically needs?
How does this affect contraception — and what if I still want a pregnancy?
Until what age do you recommend I continue hormone therapy, and why?

Questions I hear about this

I'm 38 and my doctor says I'm too young for menopause. Am I?

You're too young for typical menopause — which is exactly why premature ovarian insufficiency exists as a diagnosis. Cycle changes, flashes, or fertility trouble before 40 warrant real evaluation: repeated labs, not a single test, and not reassurance. If POI is confirmed, treatment isn't optional-extra; it protects your long-term health.

Is hormone therapy risky for someone my age?

The risk conversation you've heard mostly comes from studies of women well past menopause. For early menopause and POI, the guideline logic runs the other way: you're replacing hormones your body would normally still make, and treatment until around the typical age of menopause is generally recommended unless something specific rules it out.

Can I still get pregnant with POI?

Sometimes. Ovarian function in POI can fluctuate, and spontaneous pregnancy happens in a meaningful minority of women. That cuts both ways: if you want to conceive, that hope is real and worth discussing with a fertility specialist; if you don't, you still need contraception. Either way, don't let anyone treat the question as closed.

Does early menopause explain my weight change?

It can contribute. Losing estrogen early shifts fat distribution and metabolic rate the same way typical menopause does — just sooner, and for longer. I look at hormones and metabolic health together, and treat what's driving the change rather than handing you a generic plan.

Sources

Primary ovarian insufficiency — committee opinion — ACOG, 2017 (reaffirmed).
The 2022 hormone therapy position statement — The Menopause Society (formerly NAMS), 2022.
Menopause: identification and management (NG23) — early menopause sections — NICE, 2015 (updated).
ESHRE guideline: management of premature ovarian insufficiency — ESHRE, 2024.

Bring me this history — it's the part of the visit I care about most

One visit, $150, paid after we talk. No subscription, no package — and if I'm not the right physician for your situation, I'll say so.

I'm licensed in 15 states: Alabama, California, Florida, Georgia, Illinois, Indiana, Mississippi, Missouri, New Jersey, New York, Oklahoma, South Carolina, Tennessee, Texas, Washington. Please check yours before booking.

Book a $150 visit

Not sure yet? Ask me a question first.